Suggestion of active 3-chymotrypsin like protease (3CL Pro ) inhibitors as potential anti-SARS-CoV-2 agents using predictive QSAR model based on the combination of ALASSO with an ANN model
- 11 October 2021
- journal article
- research article
- Published by Taylor & Francis in SAR and QSAR in Environmental Research
- Vol. 32 (11) , 863-888
Abstract
The novel severe acute respiratory syndrome coronavirus (SARS CoV-2) was introduced as an epidemic in 2019 and had millions of deaths worldwide. Given the importance of this disease, the recommendation and design of new active compounds are crucial. 3-chymotrypsin-like protease (3 CLpro) inhibitors have been identified as potent compounds for treating SARS-CoV-2 disease. So, the design of new 3 CLpro inhibitors was proposed using a quantitative structure-activity relationship (QSAR) study. In this context, a powerful adaptive least absolute shrinkage and selection operator (ALASSO) penalized variable selection method with inherent advantages coupled with a nonlinear artificial neural network (ANN) modelling method were used to provide a QSAR model with high interpretability and predictability. After evaluating the accuracy and validity of the developed ALASSO-ANN model, new compounds were proposed using effective descriptors, and the biological activity of the new compounds was predicted. Ligand-receptor (LR) interactions were also performed to confirm the interaction strength of the compounds using molecular docking (MD) study. The pharmacokinetics properties and calculated Lipinski’s rule of five were applied to all proposed compounds. Due to the ease of synthesis of these suggested new compounds, it is expected that they have acceptable pharmacological properties.Keywords
Funding Information
- public, commercial, or not-for-profit sectors
This publication has 59 references indexed in Scilit:
- Comparison of Different Approaches to Define the Applicability Domain of QSAR ModelsMolecules, 2012
- A Force Field with Discrete Displaceable Waters and Desolvation Entropy for Hydrated Ligand DockingJournal of Medicinal Chemistry, 2011
- Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV MproBioorganic & Medicinal Chemistry, 2008
- The Adaptive Lasso and Its Oracle PropertiesJournal of the American Statistical Association, 2006
- The application of Kriging and empirical Kriging based on the variables selected by SCADAnalytica Chimica Acta, 2006
- From genome to drug lead: Identification of a small-molecule inhibitor of the SARS virusBioorganic & Medicinal Chemistry Letters, 2006
- Cinanserin Is an Inhibitor of the 3C-Like Proteinase of Severe Acute Respiratory Syndrome Coronavirus and Strongly Reduces Virus Replication In VitroJournal of Virology, 2005
- Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS DrugsScience, 2003
- Neural networks and genetic algorithms in drug designDrug Discovery Today, 2001